Watch our webinar on ‘The Future of Atopic Eczema Care in Ireland’
Did you miss our webinar on, The Future of Atopic Eczema Care in Ireland? No problem, watch it below. In this SkinSideOut webinar, our panel, eczema patient advocate, Paul Herriott; Consultant Dermatologist, Prof Alan Irvine; and Advanced Nurse Practitioner in Dermatology and ISF Clinical Helpline Manager, Carmel Blake talk about recent medical advancements in the […]
Webinar: The Future of Atopic Eczema Care in Ireland
This event has ended. In this SkinSideOut webinar, we take a look at The Future of Atopic Eczema Care in Ireland. You’ll hear about recent medical advancements in the treatment of eczema and what this will mean for the future; how COVID-19 has impacted dermatology services and how they have adapted to deliver care; and […]
Update on Dupilumab: HSE Drugs Group Supports Reimbursement
Potentially life-changing treatment one step closer for people struggling with moderate-to-severe atopic eczema The HSE has advised that the HSE Drugs Group, the body which decides whether or not the Irish government will fund a new medicine through the public health system, supported reimbursement of dupilumab for a defined subgroup of the full licensed indication, […]
ISF makes submission advocating for access to potentially ‘life-changing’ new treatment for Atopic Eczema
The ISF has made a submission to the National Centre for Pharmacoeconomics (NCPE) in relation to a new therapy for atopic dermatitis (also known as atopic eczema) and to advocate for wider access for patients to a potentially ‘life changing’ new drug. In 2017, the European Medicines Agency approved a drug called dupilumab (brand name: […]
When should people with Eczema / Atopic Dermatitis (AD) be offered systemic therapy?
New consensus framework to provide a structure for patients and caregivers to make a decision about systemic therapies Atopic dermatitis (AD), also known as atopic eczema, is a common, itchy and unpleasant condition. AD has significant well-established comorbidities (associated conditions) including food allergy, asthma and allergic rhinitis, in addition to newly-recognised comorbidities including those related […]
Eczema Drug Trials Show Promising Results
Japanese researchers at an early phase in clinical trials, have found that a new drug given as a single injection, reduced the itch, sleep disturbance and topical steroid use in patients with atopic eczema, according to a study published in the British Journal of Dermatology. What is atopic eczema? Atopic eczema is a common, non-contagious […]
